pharma · Chronic Lymphocytic Leukemia · Relapsing Multiple Sclerosis · TGTX
TG THERAPEUTICS
TG THERAPEUTICS, INC.
TG THERAPEUTICS is a pharma organization headquartered in Morrisville, USA. It trades on NYSE under ticker TGTX. Primary therapeutic focus areas include Chronic Lymphocytic Leukemia, Relapsing Multiple Sclerosis, Hodgkin
Company details
- Status
- Public
- HQ
- 3020 Carrington Mill Blvd, Suite 475, Morrisville, North Carolina 27560, US
- Founded
- 2011
- Employees
- 521
- Programs
- 39
- Drugs
- 23
- Patents
- 7
Quick answer
TG THERAPEUTICS is a pharma organization headquartered in Morrisville, USA. It trades on NYSE under ticker TGTX. Primary therapeutic focus areas include Chronic Lymphocytic Leukemia, Relapsing Multiple Sclerosis, Hodgkin's Lymphoma, Follicular Lymphoma, multiple sclerosis. NovaPharmaNews links 39 clinical program(s), 1 drug profile(s), and 7 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (15), phase 2 (13), phase 3 (9).
Company snapshot
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) and from several regulatory agencies outside of the U.S for its therapy as a treatment for rela
- 1 approved product(s) across US/EU regulatory metadata.
- 39 active pipeline program(s) linked via ClinicalTrials.gov.
- 7 US patent(s) indexed to this assignee profile.
Public regulatory, clinical, patent, and corporate records for TG THERAPEUTICS. Not investment advice.
Top assets
Lead pipeline drugs
- approved
- Marketed / approved
- approved
- approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for TG THERAPEUTICS.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Recent activity
Latest pipeline, patent, and corporate events for TG THERAPEUTICS.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is TG THERAPEUTICS?
-
Is TG THERAPEUTICS publicly traded?
-
What drugs does TG THERAPEUTICS develop or market?
-
What are the latest developments for TG THERAPEUTICS?
-
What therapeutic areas does TG THERAPEUTICS focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.